Nachrichten zur GW Pharmaceuticals Plc Aktie

Bayer: Das steckt hinter dem Deal mit dem Cannabis-Player GW Pharma

Bayer hat letzte Woche die Zahlen für das Geschäftsjahr 2019 vorgelegt. Während die Ergebnisse im vierten Quartal im Rahmen der…

GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer

CAMBRIDGE, United Kingdom and READING, United Kingdom, March 02, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (GW) and…

GW Pharma A Buy On Back Of Results And Corona Virus Effects

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is GW Pharmaceuticals Finally Getting Some Competition-

Zogenexs lead drug candidate may soon be approved to treat the same patients targeted by GW Pharmaceutials Epidiolex....…

GW Pharmas Epidiolex Label Expansion, EU Launch Key Growth Drivers In 2020

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) shares are retreating following the release of fourth-quarter results. Latest Ratings for GWPH …

The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharmas Earnings, COVID-19 Updates

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week…

3 Most Important Things to Know About GW Pharmaceuticals Q4 Update

Some good news and some bad news for the cannabis-focused biotech in its latest quarterly update....…

GW Pharmaceuticals PLC (GWPH) Q4 2019 Earnings Call Transcript

GWPH earnings call for the period ending December 31, 2019....…

GW Pharmaceuticals plc (GWPH) CEO Justin Gover on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharma Reports Q4 Earnings, Beats Revenue Target

Sales of its CBD-derived epilepsy drug continue to surge....…

GW Pharmaceuticals narrows loss in Q4, revenue beats

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference

LONDON and CARLSBAD, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…

GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know

GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $128.34, moving +1.46% from the previous trading session....…

Whats in Store for GW Pharmaceuticals (GWPH) Q4 Earnings-

GW Pharmaceuticals (GWPH) Q4 results likely to reflect top-line growth on strong adoption of Epidiolex and Sativex....…

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Fourth Quarter and Year Ending December 31, 2019 and Host Conference Call on February 25th, 2020

LONDON and CARLSBAD, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, "GW or "the…

GW Pharmaceuticals: Hochspekulativ, aber sehr interessant - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt im Interview mit "Der Aktionär TV" die GW Pharmaceuticals-Aktie (ISIN:…

Marion Schlegel: Evotec, Alector, GW Pharmaceuticals in der Analyse

Marion Schlegel vom Anlegermagazin DER AKTIONÄR blickt in dieser Sendung auf die aktuellen Entwicklungen in der Pharma-, Biotech- und Cannabisbranche....…

GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, GW Pharmaceuticals PLC (GWPH) closed at $129.96, marking a +0.38% move from the previous day....…

Is GW Pharmaceuticals Stock a Buy-

Should investors worry about Epidiolexs slowing sales growth?...…

Thinking about trading options or stock in Amazon.com, Beyond Meat, FedEx, GW Pharmaceuticals, or T-Mobile-

NEW YORK , Feb. 10, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMZN,…

GW Pharmaceuticals: Favorable Entry Price Arises For This High-Growth And High-Potential Biotech

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zogenixs Positive Clinical Trial Wasnt Positive Enough

Rival GW Pharmaceuticals came out the big winner, as its competing seizure drug looks more effective....…

GW Pharmaceuticals: Optimismus angebracht - Aktienanalyse

Kulmbach (www.aktiencheck.de) - GW Pharmaceuticals-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die GW…

Cannabis-Player GW Pharmaceuticals: Starke News - unglaubliches Kursziel!

Die Aktien der Cannabis-Branche haben in den vergangenen Monaten fast durch die Bank deutliche Verluste hinnehmen müssen. Hier wurde auch…

Why GW Pharmaceuticals Stock Rose 10% in January

The company has been one of the few bright spots in the struggling cannabis industry....…

BofA Sees Blockbuster Sales Potential For GW Pharmas CBD Drug Epidiolex

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), which derives a lions share of its revenues from its cannabinoid seizure drug …

GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, GW Pharmaceuticals PLC (GWPH) closed at $115.46, marking a -0.06% move from the previous day....…

GW Pharma files U.S. application for expanded use of Epidiolex

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharma submits supplemental NDA for Epidiolex to treat seizures from TSC

GW Pharmaceuticals PLC said Monday it has submitted a supplemental New Drug Application (NDA) to expand the label for…

GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to U.S. FDA for Epidiolex® (cannabidiol) for the Treatment of Tuberous Sclerosis Complex

LONDON and CARLSBAD, Calif., Feb. 03, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…